UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 17, 2021
Accession Number:
Submission Type:
CIK: 0001157075
Company Name: PharmaCyte Biotech, Inc.
File Number: 333-260849